Rainbow Coral Corp. (OTCBB:RBCC) announced that the company opened talks with its top target in the regenerative medicine industry this week regarding a possible partnership or acquisition. Rainbow Coral's potential target specializes in relieving chronic back pain from Degenerative Disc Disease using an innovative, patentable remedy derived from a patient's own cells.

"We plan to get an agreement signed with them as soon as possible in order to begin making RBCC a part of the solution for chronic pain sufferers worldwide." Chief Executive Officer Patrick Brown said.